10x Genomics EBITDA Margin 2018-2025 | TXG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for 10x Genomics (TXG) over the last 10 years. The current EBITDA margin for 10x Genomics as of March 31, 2025 is .
| 10x Genomics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.63B | $-0.13B | -20.96% |
| 2024-12-31 | $0.61B | $-0.15B | -24.71% |
| 2024-09-30 | $0.63B | $-0.16B | -24.60% |
| 2024-06-30 | $0.63B | $-0.21B | -32.75% |
| 2024-03-31 | $0.63B | $-0.23B | -36.26% |
| 2023-12-31 | $0.62B | $-0.22B | -35.54% |
| 2023-09-30 | $0.59B | $-0.19B | -32.49% |
| 2023-06-30 | $0.57B | $-0.14B | -24.82% |
| 2023-03-31 | $0.54B | $-0.15B | -27.05% |
| 2022-12-31 | $0.52B | $-0.14B | -26.36% |
| 2022-09-30 | $0.50B | $-0.13B | -25.79% |
| 2022-06-30 | $0.50B | $-0.11B | -21.49% |
| 2022-03-31 | $0.50B | $-0.06B | -11.02% |
| 2021-12-31 | $0.49B | $-0.03B | -5.09% |
| 2021-09-30 | $0.46B | $-0.42B | -91.50% |
| 2021-06-30 | $0.41B | $-0.47B | -116.01% |
| 2021-03-31 | $0.33B | $-0.50B | -151.05% |
| 2020-12-31 | $0.30B | $-0.52B | -172.24% |
| 2020-09-30 | $0.26B | $-0.12B | -44.27% |
| 2020-06-30 | $0.25B | $-0.06B | -25.10% |
| 2020-03-31 | $0.26B | $-0.04B | -14.02% |
| 2019-12-31 | $0.25B | $-0.02B | -9.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.533B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.177B | 57.48 |
| Doximity (DOCS) | United States | $11.570B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.189B | 116.26 |
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.774B | 58.97 |
| Hinge Health (HNGE) | United States | $3.628B | 0.00 |
| Privia Health (PRVA) | United States | $2.525B | 172.58 |
| Enovis (ENOV) | United States | $1.763B | 9.83 |
| Schrodinger (SDGR) | United States | $1.589B | 0.00 |
| Phreesia (PHR) | United States | $1.543B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.532B | 0.00 |
| Azenta (AZTA) | United States | $1.470B | 68.32 |
| Evolent Health (EVH) | United States | $1.323B | 112.70 |
| Omnicell (OMCL) | United States | $1.310B | 23.12 |
| Claritev (CTEV) | United States | $0.733B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.552B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.457B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.328B | 728.33 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.282B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| CapsoVision (CV) | United States | $0.218B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.107B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |